Rightslink® by Copyright Clearance Center

Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness”

Author:

Bora Lim,Sahil Seth,Clinton Yam,Lei Huo,Takeo Fujii,Jangsoon Lee,Roland Bassett,Sara Nasser,Lisa Ravenberg,Jason White,Alyson Clayborn,Gil Guerra,Jennifer K. Litton,Senthil Damodaran,Rachel Layman,Vicente Valero,Debasish Tripathy,Michael Lewis et al.

Publication:

Cell Reports Medicine

Publisher:

Elsevier

Date:

18 June 2024

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.